Conclusions: constipation is disease-related, not a lifestyle factor. More research is needed on optimal management and laxative use. 
INTRODUCTION
Constipation is common in older people [1] . It adversely affects quality of life [2] , and incurs significant healthcare costs for laxatives and the treatment of complications. Constipation is a symptom of neurological disease [3, 4] and studies show that 50% [5] to over 70% [6] of people with Parkinson's suffer from constipation; and the excess burden relative to age matched controls may be as high as 60% [7] [8] [9] [10] . Laxatives are estimated to be taken by approaching 40% of people with Parkinson's [6, 10] . Constipation is one of several autonomic system failures associated with Parkinson's [7] [8] [9] [11] [12] [13] [14] . Mamometric investigations show two causes: anorectal 'outlet' dysfunction, causing straining, and slow colonic transit, suggesting local / peripheral nervous system effects and CNS mechanisms underlie constipation [4, 5, [14] [15] [16] [17] .
Diagnosing constipation is difficult because it means different things to different people [3, 14] . Infrequent bowel movement in the absence of other symptoms (straining, hard / lumpy stools, feeling of obstruction or incomplete evacuation) may lie within the normal spectrum [18] . Constipation is assessed by objective means (for example, self report of frequency), subjectively (expressions of 'bothersomeness' or concern caused by it) or behaviour (laxative taking or other self help measures).
It is not known why only some people with Parkinson's experience constipation.
Improved understanding of the risk factors will help ensure that health professionals implement evidence -based management strategies [12] . The aim of this study was to investigate clinical, demographic and dietary factors associated with constipation in a sample of community dwelling people with Parkinson's disease.
METHODS

Recruitment and data collection
Ethical approval was obtained from the local NHS ethics committee. All people with
Parkinson's attending a specialist outpatient clinic (except new patients and those with a recorded diagnosis of dementia) were sent an information sheet about the study and a letter inviting them to take part. Where appropriate, a separate information sheet and invitation was enclosed for partners / carers, who were included in the study to provide a convenient control group, and one that shared food preparation arrangements. Those interested in participating contacted the research team, and attended an interview at their next clinic visit. Repeat invitations were mailed to non responders, but only after a 12 month delay, on ethical grounds. At the clinic interview (conducted in private), a researcher received consent (separately for patients and partner / carers). Partners were asked to self complete baseline questionnaires, whilst the researcher collected data from patients. The researcher then gave participants a four week stool diary, and explained how to complete it.
Participants were phoned after two weeks to assess progress. Completed diaries were returned in prepaid envelopes.
The target recruitment was 100 people with Parkinson's, and record reviews suggested that about 80% of community dwelling patients would have a partner / carer who could be invited to join the control group. Sample size calculations suggested that if 100 people with Parkinson's were recruited, using a 5% significance level, a comparison of patients with partner / carers (controls) will yield 80% power against a medium sized standardised difference of 0.6.
Measurement of constipation
The baseline questionnaire was used to collect retrospective self report information on participants' experiences of constipation including: the extent to which constipation was a cause for concern; frequency of bowel movements; use of prescribed and purchased over-the-counter laxatives; self help measures (increased fluid, fibre, fruit and vegetable intake, other dietary change, extra exercise); soiling and use of protection due to bowel incontinence (see Table 3 ). The first version of the Rome criterion (Rome I) was used to objectively assess whether a participant suffered from constipation. This internationally recognised standard asks subjects whether, for at least a quarter of the time during the last three months, they have: had to strain when opening their bowels; had lumpy / hard stools; had a sensation of incomplete evacuation; had less than three bowel movements per week. Constipation is present if the subject answers 'yes' to two or more of the four symptoms [19] .
To avoid inaccuracies from poor recall, diaries are recommended for collection of data on bowel function [20] . A bowel diary was purposefully developed for the study.
Records were arranged one week to a page, and participants were asked to note daily the date and time of each bowel movement, (zero if no bowel opening), and use of laxatives / home remedies. Further information was recorded for each bowel movement: minutes spent, whether they felt empty afterwards (yes/ no), straining (0= none, 1= mild, 2= moderate, 3= severe), stool consistency (referring to pictures on the Bristol Stool Form Chart [21] , range 1, separate hard lumps, like nuts (difficult to pass) to 7, watery, no solid pieces, entirely liquid). A sample of 12 diaries was independently reviewed by six nurses and continence advisors who concluded that the data generated were reliable and complete, enabling appropriate clinical interpretations to be drawn. Diary data were analysed to assess whether the bowel activity recorded met the Rome criterion (see footnote to Table 5 ). Participant's constipation status reported retrospectively at baseline was compared with that recorded prospectively in the diary.
Other variables
Baseline questionnaires were used to collect data from patients and partner / carers on factors potentially associated with constipation: socio -demographic, economic characteristics; life style behaviours, including exercise, liquid, fruit / vegetable and fibre intake; activity of daily living (ADL) disability measure [22] ; physical and mental functioning component summary scores (PCS and MCS) of SF -12 [23] , an internationally validated measure of health-related quality of life (Table 2) . Clinical information for people with Parkinson's was extracted from medical notes by a Parkinson's specialist nurse: Hoehn and Yahr disease stage [24] , number of comorbidities and prescribed medications; taking COMT inhibitors (yes/ no -because diarrhoea is a side effect); taking agonists or anticholinergics (yes/ no -because constipation is a side effect). (Table 1) . A higher proportion of people with Parkinson's than partner / carers were male; there were no significant differences between groups in other socio -demographic, economic variables (Table 2) . People with Parkinson's reported relatively high levels of independence (mean of 2, i.e. able to do activity alone with a little effort, on each item of the ADL disability scale), but in comparison to controls, their mobility, manual dexterity and PCS scores were significantly worse. Partners / carers reported eating significantly more fruit and vegetables, but there were no differences between groups in other self reported behaviours (Table 2) .
Statistical analysis
RESULTS
Characteristics of samples
TABLES 1 AND 2 GO HERE
Baseline reporting of constipation
On each measure, people with Parkinson's were significantly more likely to report constipation than controls ( Table 3 ). Measures of constipation were closely correlated (Table 4 ). Patients (controls) stating that constipation caused them a lot of concern were 8.26 (11.5) times more likely to be taking any laxative, and 14 (7.2) times more likely to be constipated according to the Rome criterion than people who stated they were not greatly concerned by constipation.
TABLES 3 AND 4 GOES HERE
Bowel incontinence
Nine percent of respondents with Parkinson's, 3.7% of partner / carer controls, reported wearing protection against faecal incontinence (Table 3) 
Stool diary analysis
People with Parkinson's were significantly more constipated than controls (Table 5) .
Lower proportions of people with Parkinson's and of partner / carers were defined as constipated (Rome criterion) in the diary analysis than in retrospective reporting at baseline (35% vs 73%, 7% vs 24.5% respectively). There was no difference in constipation status at baseline between the people who completed the stool diary and those who did not, nor between the characteristics of people whose constipation status changed between baseline and diary and the characteristics of those whose status did not (data not shown). 
Correlates of constipation
In multiple regression analysis, the only factors predictive of constipation were having Parkinson's disease (p= .003) and ADL mobility (p=.04). People with Parkinson's are nearly five times more likely to meet the Rome criterion than partner / carer controls (odds ratio 4.80, 95% CI 1.64 to 14.04). An increase of one unit in ADL mobility score raises the odds of meeting the Rome criterion by 1.15 (95% CI 1.01 to 1.31). When the two ADL variables are not in the model, only a diagnosis of Parkinson's disease is a significant predictor of constipation (odds ratio 9.38, 95% CIs 3.91 to 22.52).
Stating that constipation has been a cause for concern over adult life is significantly associated with meeting the Rome criterion at baseline (p=.031), including when Parkinson's diagnosis is incorporated in the model (p=.048). Hence, patients and partners / carers reporting constipation at baseline are equally likely to have reported concern over constipation throughout their adult life.
Amongst patients, a significant association exists between constipation and number of medications (p=.027), the major effect coming from taking >=4 medications (odds ratio relative taking 0 or 1 medication 8.62, 95% CI 1.60 to 46.45). There is no evidence of any association between constipation and number of comorbidities, having hypotension, or taking COMT inhibitors, agonists or anticholergineric medications.
DISCUSSION
The study confirms higher levels of self reported constipation amongst people with Parkinson's than partner / carer controls. The excess burden (according to Rome I criterion) amongst patients, compared to partner / carer controls (48% at baseline (73% vs 25%), and 28% (35% vs7%) stool diary) is comparable to other studies [7] [8] [9] [10] . Retrospectively, respondents self report higher levels of constipation according to the objective Rome criterion than by subjective (cause of concern) and behavioural (use of laxatives or other self help measures) indicators. The lower level of constipation reported through prospective diary data contrasts with other research which suggests that diaries over estimate constipation by under reporting stool frequency [5] . In this study, the discrepancy may arise because the retrospective reporting at baseline used the validated Rome criterion, with a 3 month reference period, but the diary data was collected over four weeks (to avoid jeopardising data quality by increasing participant burden). Applying the Rome criterion to one month of data might be expected a priori to result in a lower observed frequency of constipation because less time has elapsed for constipation episodes to occur.
Data from the baseline questionnaire suggest that only ADL mobility and having a diagnosis of Parkinson's disease are significantly associated with constipation. The link between female gender and psychological morbidity and constipation identified by other researchers [3, 15, 25] was not found. In the patient sample, the number of medications taken is an independent predictor of constipation. Anticholinergic medications are known to have a constipating side effect (26, 29, 45 ), but may not have been significant in our study because relatively small numbers of patients were taking them. Unlike other studies, the evidence reported here failed to find an association between constipation in Parkinson's and the disease process severity, diet or activity [4, 7, 12, 26] and low fibre, fluid intake or lack of exercise [5, 14, 16, 17] . This may be because the data collection was not sufficiently detailed, or 'doses' were inadequate The limitations of this study are that partner / carer recruitment fell short of expectations (47 vs 78). Many partners/ carers were not willing to take part, and this affected the statistical comparisons between groups. Other trials of constipation have also reported problems recruiting participants due to the sensitive nature of the subject [18] . The representativeness of people recruited to the study is not known.
Gender imbalance in the sample (more women in the carer group than patient group) may affect the interpretation of the findings if constipation is not equally experienced by men and women. The patient sample covered all disease stages, although 50% were Hoehn and Yahr stage 2, and as a group, they reported relatively little disability in ADL. The most up-to-date version of the Rome criterion [30] was not used in the study because, in piloting, participants found the lengthened reference period (12 rather than three months) problematical.
This study suggests that constipation is disease related, rather than a life style issue.
Constipation -related problems cause daily concern for significant numbers of people, and there is a need for further research into optimal management regimens, including robust trials to provide an evidence-base for practitioners. # To meet the Rome criterion: for at least a quarter of the time any two of the following symptoms must be present: straining when opening bowels (defined as a mean straining score >1 from diary entries); lumpy or hard stools (mean Bristol stool score <3); sensation of incomplete evacuation (report not feeling bowels empty > 33% of bowel movements); <3 bowel movements per week (mean of < 3/7 = 0.43). 
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